We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Boosting Tumor Cell Drug Sensitivity

News   Oct 31, 2018 | Original story from the University of California San Diego

 
Boosting Tumor Cell Drug Sensitivity

Pancreatic cancer cells deficient in the expression of the human gene known as Schlafen 11 and resistant to chemotherapy (left panels) were re-sensitized to chemotherapeutic treatment (middle and right panels) by inhibiting the expression of the transfer RNA known as tRNA-Leu-TAA through specially designed antisense oligonucleotides. Credit: Manqing Li, Michael David Lab, UC San Diego

 
 
 

RELATED ARTICLES

Compound Kills Chemotherapy-resistant Cancer Cells

News

Study reports the discovery of a compound that is capable of killing chemotherapy-resistant glioblastoma-initiating cells (GICs), raising hopes of producing drugs capable of eradicating refractory tumors with low toxicity.

READ MORE

Creatine Fuels T Cells’ Fight Against Cancer

News

Creatine serves as a molecular battery for immune cells by storing and distributing energy to fuel their fight against cancer, according to a new study.

READ MORE

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE